Literature DB >> 1701521

Characterization of the in vivo release of dopamine as recorded by different types of intracerebral microdialysis probes.

M Santiago1, B H Westerink.   

Abstract

Microdialysis of dopamine was performed in the striatum with four different microdialysis cannulas: a trans-cerebral probe, a U-shaped probe, a I-shaped probe and a commercially available I-shaped probe (Carnegie). The commercial cannula was studied with as well as without a guide cannula. The effect of infusion of tetrodotoxin (TTX) or calcium free-Ringer solution on the dialysate content of dopamine released was determined 2 h after implantation (day 1) as well as 24 h after implantation (day 2). Two hours after implantation, all cannulas displayed a certain amount of TTX-independent overflow of dopamine. The best results were obtained with the I-shaped cannula: already 2 h after implantation of the probe, about 85% of the release of dopamine was TTX-dependent. In case of the trans-cerebral cannula and the Carnegie cannula (implanted without guide in anesthetized rats), 70-75% of the output of dopamine was TTX-dependent. When the Carnegie cannula was implanted with a guide cannula, only 45% of the dopamine output was TTX-dependent. The responses to calcium-free perfusion were much more variable. Dopamine output in I-shaped and the U-shaped probes was virtually insensitive to calcium-free perfusion in acute experiments. Twenty-four hours after implantation of the probes, the calcium- and TTX-dependency was much more pronounced. All types of cannulas studied now sampled dopamine that was completely TTX-dependent. Calcium-free perfusion caused a reproducible disappearance of dopamine from the dialysates to 30% of controls, in all cannulas studied. When the removable Carnegie cannula was re-implanted 24 h after its first implantation, 91% of the dopamine overflow was TTX-sensitive. These results confirm earlier conclusions that microdialysis experiments should be carried out at least 24 h after implantation of the probe.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1701521     DOI: 10.1007/bf00169457

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  11 in total

1.  Tissue levels and in vivo release of tachykinins and GABA in striatum and substantia nigra of rat brain after unilateral striatal dopamine denervation.

Authors:  N Lindefors; E Brodin; U Tossman; J Segovia; U Ungerstedt
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

2.  Repeated haloperidol administration changes basal release of striatal dopamine and subsequent response to haloperidol challenge.

Authors:  W Zhang; H Tilson; M K Stachowiak; J S Hong
Journal:  Brain Res       Date:  1989-04-10       Impact factor: 3.252

3.  Amino acids in rat striatal dialysates: methodological aspects and changes after electroconvulsive shock.

Authors:  J Korf; K Venema
Journal:  J Neurochem       Date:  1985-11       Impact factor: 5.372

4.  Trans-striatal dialysis coupled to reverse phase high performance liquid chromatography with electrochemical detection: a new method for the study of the in vivo release of endogenous dopamine and metabolites.

Authors:  A Imperato; G Di Chiara
Journal:  J Neurosci       Date:  1984-04       Impact factor: 6.167

5.  Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats.

Authors:  T E Robinson; I Q Whishaw
Journal:  Brain Res       Date:  1988-05-31       Impact factor: 3.252

6.  Chronic use of intracerebral dialysis for the in vivo measurement of 3,4-dihydroxyphenylethylamine and its metabolite 3,4-dihydroxyphenylacetic acid.

Authors:  B H Westerink; M H Tuinte
Journal:  J Neurochem       Date:  1986-01       Impact factor: 5.372

7.  Characterization of in vivo dopamine release as determined by brain microdialysis after acute and subchronic implantations: methodological aspects.

Authors:  B H Westerink; J B De Vries
Journal:  J Neurochem       Date:  1988-09       Impact factor: 5.372

8.  The use of tetrodotoxin for the characterization of drug-enhanced dopamine release in conscious rats studied by brain dialysis.

Authors:  B H Westerink; J Tuntler; G Damsma; H Rollema; J B de Vries
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-11       Impact factor: 3.000

9.  Apomorphine and haloperidol effects on striatal 3H-dopamine release in anesthetized, awake restrained and freely moving rats.

Authors:  U Spampinato; J A Girault; J Danguir; H E Savaki; J Glowinski; M J Besson
Journal:  Brain Res Bull       Date:  1986-02       Impact factor: 4.077

10.  The significance of extracellular calcium for the release of dopamine, acetylcholine and amino acids in conscious rats, evaluated by brain microdialysis.

Authors:  B H Westerink; H M Hofsteede; G Damsma; J B de Vries
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-04       Impact factor: 3.000

View more
  29 in total

1.  Characterization of the decrease of extracellular striatal dopamine induced by intrastriatal morphine administration.

Authors:  T P Piepponen; J A Mikkola; M Ruotsalainen; D Jonker; L Ahtee
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

2.  Consequences of static and pulsatile pressure on transmembrane exchanges during in vitro microdialysis: implication for studies in cardiac physiology.

Authors:  E M Siaghy; B Oesterlé; A Kheiri; P Halejcio-Delophont; D Ungureanu-Longrois; J P Villemot; P M Mertes
Journal:  Med Biol Eng Comput       Date:  1999-03       Impact factor: 2.602

3.  The effect of intrastriatal application of directly and indirectly acting dopamine agonists and antagonists on the in vivo release of acetylcholine measured by brain microdialysis. The importance of the post-surgery interval.

Authors:  P De Boer; G Damsma; Q Schram; J C Stoof; J Zaagsma; B H Westerink
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-02       Impact factor: 3.000

Review 4.  A review of the effects of FSCV and microdialysis measurements on dopamine release in the surrounding tissue.

Authors:  Andrea Jaquins-Gerstl; Adrian C Michael
Journal:  Analyst       Date:  2015-06-07       Impact factor: 4.616

5.  Activation of a nitric-oxide-sensitive cAMP pathway with phencyclidine: elevated hippocampal cAMP levels are temporally associated with deficits in prepulse inhibition.

Authors:  Daniel Klamer; Erik Pålsson; Kim Fejgin; Jianhua Zhang; Jörgen A Engel; Lennart Svensson
Journal:  Psychopharmacology (Berl)       Date:  2004-12-24       Impact factor: 4.530

6.  Acute depression of energy metabolism after microdialysis probe implantation is distinct from ischemia-induced changes in mouse brain.

Authors:  Rachita K Sumbria; Jochen Klein; Ulrich Bickel
Journal:  Neurochem Res       Date:  2010-09-28       Impact factor: 3.996

Review 7.  A review of flux considerations for in vivo neurochemical measurements.

Authors:  David W Paul; Julie A Stenken
Journal:  Analyst       Date:  2015-06-07       Impact factor: 4.616

8.  In vivo release of dopamine from rat striatum, substantia nigra and prefrontal cortex: differential modulation by baclofen.

Authors:  M Santiago; A Machado; J Cano
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

9.  The release of dopamine from nerve terminals and dendrites of nigrostriatal neurons induced by excitatory amino acids in the conscious rat.

Authors:  B H Westerink; M Santiago; J B De Vries
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-05       Impact factor: 3.000

10.  Synergistic dopamine increase in the rat prefrontal cortex with the combination of quetiapine and fluvoxamine.

Authors:  Damiaan Denys; André A Klompmakers; Herman G M Westenberg
Journal:  Psychopharmacology (Berl)       Date:  2004-05-11       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.